[Other] Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

 Close Closed
Marilena Post time 2024-6-17 19:09:23 | Show all posts |Read mode
Reward10points




Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    80

Latest Reply

Return to the list